We are live on ! Find out more
ACIU icon

AC Immune
ACIU

40 hedge funds and large institutions have $100M invested in AC Immune in 2019 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more capital invested

Capital invested by funds: $90.6M → $100M (+$9.74M)

0.21% more ownership

Funds ownership: 26.54% → 26.75% (+0.21%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less funds holding

Funds holding: 41 → 40 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

15% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 13

Holders
40
Holders Change
-1
Holders Change %
-2.44%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
11
Reduced
13
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$12M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$451K
3
Millennium Management
Millennium Management
New York
+$286K
4
Artisan Partners
Artisan Partners
Wisconsin
+$229K
5
Citadel Advisors
Citadel Advisors
Florida
+$216K

Top Sellers

Rank Fund Capital Flow
1
DFO
Duquesne Family Office
New York
-$6.69M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.49M
3
PM
Prosight Management
Texas
-$747K
4
VF
Virtu Financial
New York
-$397K
5
Deutsche Bank
Deutsche Bank
Germany
-$341K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$54.5M +$12M +2,363,900 +32%
Temasek Holdings
2
Temasek Holdings
Singapore
$14.5M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$7.78M -$3.49M -684,539 -33%
AG
4
Artal Group
Luxembourg
$5.55M – – –
BlackRock
5
BlackRock
New York
$3.73M -$130K -25,414 -4%
PM
6
Prosight Management
Texas
$3.13M -$747K -146,641 -21%
Renaissance Technologies
7
Renaissance Technologies
New York
$1.38M +$142K +27,789 +13%
Millennium Management
8
Millennium Management
New York
$1.25M +$286K +56,215 +33%
Artisan Partners
9
Artisan Partners
Wisconsin
$1.24M +$229K +44,861 +25%
TCM
10
Tekla Capital Management
Massachusetts
$954K – – –
Citadel Advisors
11
Citadel Advisors
Florida
$924K +$216K +42,414 +34%
AA
12
ALPS Advisors
Colorado
$785K -$109K -21,335 -13%
Wells Fargo
13
Wells Fargo
California
$664K – – –
BFM
14
Boothbay Fund Management
New York
$620K +$88.1K +17,288 +18%
Acadian Asset Management
15
Acadian Asset Management
Massachusetts
$492K +$451K +88,493 New
Morgan Stanley
16
Morgan Stanley
New York
$395K -$3.39K -666 -0.9%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$296K +$1.26K +248 +0.5%
State of New Jersey Common Pension Fund D
18
State of New Jersey Common Pension Fund D
New Jersey
$294K -$129K -25,246 -32%
AC
19
Athanor Capital
New York
$234K +$215K +42,100 New
CLOS
20
Compagnie Lombard Odier SCmA
Switzerland
$197K – – –
State Street
21
State Street
Massachusetts
$180K – – –
ARTA
22
A.R.T. Advisors
New York
$172K -$124K -24,248 -44%
Deutsche Bank
23
Deutsche Bank
Germany
$144K -$341K -66,847 -72%
Goldman Sachs
24
Goldman Sachs
New York
$129K -$47K -9,214 -28%
Marshall Wace
25
Marshall Wace
United Kingdom
$110K -$43.1K -8,462 -30%
1
2

ACIU Hedge Fund Activity: Q2 2019 in Review

40 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q2 2019, worth a combined $100M — up 11% from $90.6M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ACIU and 9 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 11 added.

The largest buyer was BVF Inc, adding an estimated $12M. The largest seller was Duquesne Family Office, exiting entirely with an estimated $6.69M sold.

  • 40 institutional investors held AC Immune (ACIU) as of Q2 2019, down from 41 in Q1 2019.
  • Funds reported $100M of AC Immune stock for Q2 2019, up 11% quarter-over-quarter.
  • 9 funds opened new AC Immune positions in Q2 2019 and 10 closed out, a net change of -1 holder.
  • The largest AC Immune buyer in Q2 2019 was BVF Inc, an estimated $12M added.
  • The largest AC Immune seller in Q2 2019 was Duquesne Family Office, an estimated $6.69M sold.

Based on aggregated 13F filings for Q2 2019.